Talk Precision Medicine
Talk Precision Medicine
18 / 04 / 2022 | Florence Raynaud
Florence Raynaud understands that small molecule drug discovery in an academic setting is all about teamwork. She uses ADME screening methods, driven by LC-MS, to understand and predict how compounds will be absorbed, distributed and metabolized. She focuses on finding the right compounds to move forward for in vivo testing, and she shows examples of some preclinical models that were validated in the clinical environment.
Florence Raynaud, PhD
Group Leader Pharmacokinetics and Metabolomics
Institute of Cancer Research